INSIGHTS ON DRUG DEVELOPMENT
-
Navigating The Regulatory Space To Biosimilar Approval
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
-
Scale Your Viral Vector Production With A Streamlined Bioreactor System
Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Nose To Brain (N2B) Drug Delivery – Benefits And Challenges
Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).
-
Overcoming Challenges In Ophthalmic Formulations8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
Strategies For The Development Of Safe And Effective Pediatric Formulations5/12/2025
Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.
-
Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology3/4/2026
Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.
-
Analytical Method Development For Paediatric Oral Dose Products9/9/2026
This article explores the key formulation and analytical challenges that pharmaceutical companies face when creating safe, effective, and age-appropriate treatments for paediatric populations.
-
Right From The Start: Smarter Developability For Stronger Formulations2/4/2026
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
DRUG DEVELOPMENT SOLUTIONS
-
Our solutions are tailored to guide and optimize your efforts, so you can be confident in your development strategy and execution plan. While we have a wide range of offerings ready and available, we are driven by one goal—to help you successfully realize yours.
-
The THUNDER Imager Tissue allows real-time fluorescence imaging of 3D tissue sections typically used in neuroscience and histology research. Acquire rich, detailed images of thick tissues free of haze from out-of-focus blur.
Even fine structures deep in tissues can be resolved thanks to Computational Clearing, an innovative Leica technology. Image detailed morphological structures like axons and dendrites of neurons in a brain slice. The high image quality, even with thick tissue sections, is combined with the well-known speed, fluorescence efficiency, and ease of use of widefield microscopes.
-
We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
-
Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.
-
Successful development relies on a deep understanding of a molecule’s unique characteristics. We have the knowledge and expertise to realize the true potential of your molecule, regardless of its complexity.